PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RCKT vs. UFO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between RCKT and UFO is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

RCKT vs. UFO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rocket Pharmaceuticals, Inc. (RCKT) and Procure Space ETF (UFO). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember2025
-43.35%
0.49%
RCKT
UFO

Key characteristics

Sharpe Ratio

RCKT:

-1.20

UFO:

1.28

Sortino Ratio

RCKT:

-2.16

UFO:

1.95

Omega Ratio

RCKT:

0.77

UFO:

1.23

Calmar Ratio

RCKT:

-0.73

UFO:

0.69

Martin Ratio

RCKT:

-1.71

UFO:

5.98

Ulcer Index

RCKT:

36.30%

UFO:

5.76%

Daily Std Dev

RCKT:

51.71%

UFO:

26.89%

Max Drawdown

RCKT:

-94.90%

UFO:

-50.33%

Current Drawdown

RCKT:

-85.40%

UFO:

-22.65%

Returns By Period

In the year-to-date period, RCKT achieves a -17.98% return, which is significantly lower than UFO's -1.25% return.


RCKT

YTD

-17.98%

1M

-12.18%

6M

-54.82%

1Y

-60.59%

5Y*

-13.09%

10Y*

N/A

UFO

YTD

-1.25%

1M

4.18%

6M

38.76%

1Y

34.27%

5Y*

-1.95%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RCKT vs. UFO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCKT
The Risk-Adjusted Performance Rank of RCKT is 33
Overall Rank
The Sharpe Ratio Rank of RCKT is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of RCKT is 11
Sortino Ratio Rank
The Omega Ratio Rank of RCKT is 33
Omega Ratio Rank
The Calmar Ratio Rank of RCKT is 77
Calmar Ratio Rank
The Martin Ratio Rank of RCKT is 22
Martin Ratio Rank

UFO
The Risk-Adjusted Performance Rank of UFO is 4747
Overall Rank
The Sharpe Ratio Rank of UFO is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of UFO is 5353
Sortino Ratio Rank
The Omega Ratio Rank of UFO is 4848
Omega Ratio Rank
The Calmar Ratio Rank of UFO is 3232
Calmar Ratio Rank
The Martin Ratio Rank of UFO is 5353
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RCKT vs. UFO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Rocket Pharmaceuticals, Inc. (RCKT) and Procure Space ETF (UFO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RCKT, currently valued at -1.20, compared to the broader market-2.000.002.004.00-1.201.28
The chart of Sortino ratio for RCKT, currently valued at -2.16, compared to the broader market-4.00-2.000.002.004.00-2.161.95
The chart of Omega ratio for RCKT, currently valued at 0.77, compared to the broader market0.501.001.502.000.771.23
The chart of Calmar ratio for RCKT, currently valued at -0.74, compared to the broader market0.002.004.006.00-0.740.69
The chart of Martin ratio for RCKT, currently valued at -1.71, compared to the broader market-10.000.0010.0020.00-1.715.98
RCKT
UFO

The current RCKT Sharpe Ratio is -1.20, which is lower than the UFO Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of RCKT and UFO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
-1.20
1.28
RCKT
UFO

Dividends

RCKT vs. UFO - Dividend Comparison

RCKT has not paid dividends to shareholders, while UFO's dividend yield for the trailing twelve months is around 2.01%.


TTM202420232022202120202019
RCKT
Rocket Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UFO
Procure Space ETF
2.01%1.98%1.90%3.19%1.00%1.07%0.44%

Drawdowns

RCKT vs. UFO - Drawdown Comparison

The maximum RCKT drawdown since its inception was -94.90%, which is greater than UFO's maximum drawdown of -50.33%. Use the drawdown chart below to compare losses from any high point for RCKT and UFO. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-84.36%
-22.65%
RCKT
UFO

Volatility

RCKT vs. UFO - Volatility Comparison

Rocket Pharmaceuticals, Inc. (RCKT) has a higher volatility of 15.05% compared to Procure Space ETF (UFO) at 10.04%. This indicates that RCKT's price experiences larger fluctuations and is considered to be riskier than UFO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
15.05%
10.04%
RCKT
UFO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab